Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Stroke. 2014 Aug 26;45(10):2989–2994. doi: 10.1161/STROKEAHA.114.005789

Table 5.

Cause of death by treatment assignment

Number of deaths Hazard ratio (95%CI)

Aspirin Clopidogrel + aspirin +

All participants
    All deaths 78 113 1.5 (1.1, 2.0)
    Vascular* 25 45 1.9 (1.1, 3.0)
    Non-vascular 31 39
    Uncertain cause 22 29

Ischemic heart disease ± stage I/ II hypertension at entry
    All deaths 11 30 2.9 (1.4, 5.8)
    Vascular* 4 14 3.8 (1.2, 12)
    Non-vascular 4 9
    Uncertain cause 3 7

Normotensive/pre-hypertensive and no ischemic heart disease at entry
    All deaths 8 28 3.3 (1.5, 7.3)
    Vascular* 0 11 >60 (0.51,> 1000)
    Non-vascular 6 9
    Uncertain cause 2 8

Stage I/II hypertension and no ischemic heart disease at entry
    All deaths 59 55 0.98 (0.68, 1.4)
    Vascular* 21 20 1.0 (0.54, 1.8)
    Non-vascular 21 21
    Uncertain cause 17 14
*

Includes definite and probable vascular deaths (defined in supplementary appendix)